NEOVASC INC
Share · CA64065J3047 · NVCN · A2PM65 (XTSE)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NEOVASC INC
No Price
Company Profile for NEOVASC INC Share
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Company Data
Name NEOVASC INC
Company Neovasc Inc.
Symbol NVCN
Website
https://www.neovasc.com
Primary Exchange 
TSX
TSX
WKN A2PM65
ISIN CA64065J3047
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Fredericus A. Colen
Market Capitalization 83 Mio
Country Canada
Currency CAD
Employees 0,0 T
Address 13562 Maycrest Way, V6V 2J7 Richmond
IPO Date 2001-05-23
Stock Splits
| Date | Split |
|---|---|
| 29.04.2022 | 1:25 |
| 02.07.2019 | 1:10 |
| 21.09.2018 | 1:100 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | NVCN |
More Shares
Investors who hold NEOVASC INC also have the following shares in their portfolio:
